ActiveGRANT

DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

Department of DefenseDept. of the Army -- USAMRAA

AI Overview

This DoD award supports clinical translational research to advance tuberous sclerosis complex diagnosis, prognosis, and treatments from promising preclinical findings toward real-world clinical application. Multi-PI teams can collaborate on moving TSC research closer to patient care.

This summary is AI-generated from the official solicitation.

Key Details

Agency
Department of Defense
Funding Amount
—
Release Date
May 5, 2026
Due Date
August 6, 2026

Official Description

<p><strong>Summary:</strong> The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of tuberous sclerosis complex (TSC).</p><p><br></p><p><strong>Distinctive Features:</strong> <strong><em>This funding mechanism allows for multiple Principal Investigat...
View on official source

Change History

Opportunity AddedMay 5, 2026 at 7:46 PM

DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

New Grants.gov opportunity: DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial